Spark Therapeutics Reports 2018 Financial Results and Recent Business Progress
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- SpaceX shares fall as second lockup period ends
- Supermicro probe finds no senior management link to export violations
- Werewolf Therapeutics sells platform assets to EMD Serono for $33M
Spark Therapeutics (ONCE) PT Lowered to $46 at BMO Capital
February 19, 2019 3:38 PM ESTBMO Capital analyst Matthew Luchini lowered the price target on Spark Therapeutics (NASDAQ: ONCE) to $46.00 (from $48.00) while maintaining a Market Perform rating following results.
... More